EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
65 hedge funds and large institutions have $31.9M invested in Eagle Pharmaceuticals, Inc. in 2024 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 11 increasing their positions, 28 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
65
Holders Change
-10
Holders Change %
-13.33%
% of All Funds
0.94%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
11
Reduced
28
Closed
21
Calls
$3.74M
Puts
$4K
Net Calls
+$3.73M
Net Calls Change
-$1.93M
Top Buyers
Top Sellers
| 1 |
LSV Asset Management
Chicago,
Illinois
|
-$1.65M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
-$1.2M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$1.02M |
| 4 |
PA
Perceptive Advisors
New York
|
-$971K |
| 5 |
Millennium Management
New York
|
-$940K |
